Structure/Function Claim Nutritive Value Debate Reopened By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking feedback on both its current regulatory approach to dietary supplement products bearing nutritive value-based structure/function claims and the potential impact of a policy reversal on the issue.
You may also be interested in...
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
Nutritive Value Claim Disclaimer Undermines Consumer Confidence - Perrigo
Requiring the DSHEA disclaimer on dietary supplements making nutritive valued-based structure/function claims would dissuade consumers from buying products that provide significant, well-recognized health benefits, Perrigo tells FDA.
Pregnancy Structure/Function Claims Prompt Capitol Hill Attention
FDA's reversal on structure/function claims for pregnancy-related conditions is likely to reinvigorate Capitol Hill debate over the agency's regulation of dietary supplements.